Multifunctional biological roles of Fusaric acid and its derivatives in the Diverse Kingdoms of Life: Insights from More Than Nine Decades of Research.
{"title":"Multifunctional biological roles of Fusaric acid and its derivatives in the Diverse Kingdoms of Life: Insights from More Than Nine Decades of Research.","authors":"Truong Thanh Tung, Pham Bao Phuong, Dinh Ngoc Minh, Nguyen Cao Huy, Nguyen Phuong Anh, Nguyen Khanh Linh, Nguyen Minh Duc","doi":"10.1007/s11095-026-04209-x","DOIUrl":null,"url":null,"abstract":"<p><p>Fusaric acid (5-butylpicolinic) is a mycotoxin produced by Fusarium species as a biological response to external environmental factors. It exhibits hepatotoxicity in humans upon consumption of contaminated agricultural products. The compound was first reported nearly 92 years ago by Yabuta et al. Interestingly, Fusarium spp. can produce this compound in very large amounts, up to 1080 μg per gram of total biomass. However, the primary biological function of fusaric acid is still not fully understood. Numerous studies have attempted to clarify the biological functions of fusaric acid across various species, including virus, fungi, bacteria, mammals, and humans. Several preclinical studies and clinical trials have evaluated its therapeutic potential for human diseases. However, despite these efforts, fusaric acid has not progressed into an approved therapeutic agent, highlighting both its biological complexity and the challenges associated with its clinical development. To date, none of the works have comprehensively enumerated the multifunctional biological roles of fusaric acid and its derivatives. In this review, marking the 90th + anniversary of its discovery, we discuss the most notable roles of fusaric acid across diverse kingdoms of life.</p>","PeriodicalId":20027,"journal":{"name":"Pharmaceutical Research","volume":" ","pages":"3011-3034"},"PeriodicalIF":4.1000,"publicationDate":"2026-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmaceutical Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11095-026-04209-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/24 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Fusaric acid (5-butylpicolinic) is a mycotoxin produced by Fusarium species as a biological response to external environmental factors. It exhibits hepatotoxicity in humans upon consumption of contaminated agricultural products. The compound was first reported nearly 92 years ago by Yabuta et al. Interestingly, Fusarium spp. can produce this compound in very large amounts, up to 1080 μg per gram of total biomass. However, the primary biological function of fusaric acid is still not fully understood. Numerous studies have attempted to clarify the biological functions of fusaric acid across various species, including virus, fungi, bacteria, mammals, and humans. Several preclinical studies and clinical trials have evaluated its therapeutic potential for human diseases. However, despite these efforts, fusaric acid has not progressed into an approved therapeutic agent, highlighting both its biological complexity and the challenges associated with its clinical development. To date, none of the works have comprehensively enumerated the multifunctional biological roles of fusaric acid and its derivatives. In this review, marking the 90th + anniversary of its discovery, we discuss the most notable roles of fusaric acid across diverse kingdoms of life.
期刊介绍:
Pharmaceutical Research, an official journal of the American Association of Pharmaceutical Scientists, is committed to publishing novel research that is mechanism-based, hypothesis-driven and addresses significant issues in drug discovery, development and regulation. Current areas of interest include, but are not limited to:
-(pre)formulation engineering and processing-
computational biopharmaceutics-
drug delivery and targeting-
molecular biopharmaceutics and drug disposition (including cellular and molecular pharmacology)-
pharmacokinetics, pharmacodynamics and pharmacogenetics.
Research may involve nonclinical and clinical studies, and utilize both in vitro and in vivo approaches. Studies on small drug molecules, pharmaceutical solid materials (including biomaterials, polymers and nanoparticles) biotechnology products (including genes, peptides, proteins and vaccines), and genetically engineered cells are welcome.